2019 AAPM Annual Meeting
Back to session list

Session Title: Automation and Scripting in the Clinic
Question 1: For lung tumors, simulations of full adapt (i.e. daily replanning) have shown that a single midtreatment adaptation achieves approximately what percentage of benefit (relative to full adapt) for target dose escalation and normal tissue sparing?
Reference:Benefits of adaptive radiation therapy in lung cancer as a function of replanning frequency. Dial C, Weiss E, Siebers JV, Hugo GD. Med Phys. 2016 Apr;43(4):1787
Choice A:10-25%
Choice B:30-45%
Choice C:50-65%
Choice D:80-95%
Question 2: How much treatment planning time savings has been shown to be possible when producing breast plans using an automated script vs. manual treatment planning approaches?
Reference:Usefulness of EZFluence software for radiotherapy planning of breast cancer treatment. Yoder T, Hsia AT, Xu Z, Stessin A, Ryu S. Med Dosim. 2019 Jan 2. pii: S0958-3947(18)30137-7. doi: 10.1016/j.meddos.2018.12.001. [Epub ahead of print]
Choice A:25%
Choice B:45%
Choice C:65%
Choice D:85%
Question 3: Which of the following is not true regarding the use of checklist?
Reference:B. Burian, A. Clebone, K. Dismukes, and K. Ruskin, “More Thank a Tick Box: Medical Checklists Development, Design, and Use” Anesthesia & Analgesia 2018;126(1):223-32
Choice A:They are an important safety feature that should be built into health care.
Choice B:Increasing checklist items always results in improved safety.
Choice C:Implementation of an automated system increases the reliability of a checklist.
Choice D:Automated checklist allows time for greater investigation into variations.
Question 4: Automated Weekly Chart Checks removes the responsibility to perform weekly chart checks.
Reference:SW. Hadley, ML Kessler, DW Litzenberg, C Lee, J Irrer, X Chen, E Acosta, G Weyburne, W Keranen, k Lam, E Covington, KC Younge, MM Matuszak, and JM Moran, “ SafetyNet: streamlining and automating QA in radiotherapy” Journal of Applied Clinical Medical Physics 2016;17(1):387-95
Choice A:True
Choice B:False
Question 5: Which of the following are the main ways the Eclipse Scripting can be implemented?
Reference:Varian Medical Systems. Eclipse Scripting API Reference Guide (P1021698-003-C). November 2017. Pages 31-32
Choice A:Plug-in single file
Choice B:Plug-in binary
Choice C:Stand-alone executable
Choice D:A and B
Choice E:A, B, and C
Question 6: What does the API provide that make it easy to locate an associated DICOM file associated to a series, image, or plan?
Reference:Carden, R. (2018). Daemons: A tour through Varian’s DICOM API. In J. Pyyry & W. Keranen (Eds.), Varian APIs: A handbook for programming in the Varian oncology software ecosystem (pp.47-48)
Choice A:Patient name
Choice B:DICOM UIDs
Choice C:Plan ID
Choice D:DICOM tags
Choice E:Series name
Question 7: Compared to manual treatment planning, which has been shown to be true for automated treatment planning?
Reference:Kisling K et al. A risk assessment of automated treatment planning and recommendations for clinical deployment. Med Phys. 2019 Apr 19. doi: 10.1002/mp.13552. Della Gala G et al. Fully automated VMAT treatment planning for advanced-stage NSCLC patients. Strahlenther Onkol. 2017 May;193(5):402-409. Court LE et al. Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System. J Vis Exp. 2018 Apr 11;(134). doi: 10.3791/57411.
Choice A:Treatment planning time reduced by 50% or more, physicians determine plans clinically acceptable for 50% or more, variability in planning approaches are substantially reduced.
Choice B:Costs for automated planning are substantially higher than manual
Choice C:Automated planning is only applicable for IMRT or VMAT
Choice D:Automated planning eliminates need for dosimetrists, physicians and physicians to be involved in treatment planning.
Question 8: Which statement is true about automated planning solutions?
Reference:Krayenbuehl J et al. Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer. Radiat Oncol. 2018 Sep 10;13(1):170. doi: 10.1186/s13014-018-1113-z. Court LE et al. Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System. J Vis Exp. 2018 Apr 11;(134). doi: 10.3791/57411. Della Gala G et al. Fully automated VMAT treatment planning for advanced-stage NSCLC patients. Strahlenther Onkol. 2017 May;193(5):402-409.
Choice A:They have only been shown to work for a limited number of treatment planning systems
Choice B:The approach is only applicable to targets without large concavities
Choice C:Automated planning solutions do not work for sites where the dose distribution needs to be directed along a tangential axis e.g. breast
Choice D:Automated planning has been shown to work for a broad range of planning systems, and target sites for 3D, VMAT and IMRT planning
Question 9: What currently is the primary limitation in achieving automated collision detection?
Reference:Tsiakalos, MF, et al. “Graphical treatment simulation and automated collision detection for conformal and stereotactic radiotherapy treatment planning.” MedPhys 2001; 28(7): 1359-63.
Choice A:Inaccuracy in machine hardware dimension modeling
Choice B:Lack of precision detection and decision algorithm
Choice C:Incomplete coverage of the CT over the entirety of the patient
Choice D:Unwillingness of the physicists and therapists to trust the result of current detection algorithm
Choice E:Difficulty in determining the exact location of the iso with respect to the patient and the hardwares (nozzle, table, and accessories)
Question 10: Which of the following is false:
Reference:Wu, Binbin, et al. “Patient geometry‐driven information retrieval for IMRT treatment plan quality control.” MedPhys 2009; 36(12): 5497-5505.
Choice A:Past patient treatment plan data can be used to personalize the dosimetric quality metrics for a new patient.
Choice B:The utility of past patient data to obtain personalized metrics is subject to the quality of treatment for prior patients.
Choice C:Data driven models for quality continually improve with time with more patient data
Choice D:None of the above
Back to session list